On the recordJune 10, 2014
This hearing today has very real implications for patients everywhere. How do we ensure that drug and device companies have the right incentives to discover important new treatments for disease?
Source
congress.govEditor's note · Context
Waxman emphasizes the importance of incentives for drug and device companies to innovate.
Share
More from Henry Waxman
Dec 2, 2014
We need to make sure that companies and regulators can keep pace with innovation.
Mar 24, 2021
Sadly, this deadly habit begins with our kids. In many cases they become hooked quickly and develop a lifelong addiction that is nearly impossible to break.
Nov 20, 2014
I demand a recorded vote. The CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentleman from California will be postponed. Amendment No. 2 Offered by Mr. Whitfield The CHAIR. It is now in…
Other voices in this conversation
